InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (32 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
32
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Brainard Diana, Chairman & CEO. Officer active across 2 companies, notably Allovir, Inc.. Aggregated, 41 filings have been recorded. Breakdown: 0 buy · 32 sells. Total volume traded: €618k. Activity tracked since 17 May 2021. The latest transaction was filed on 19 November 2024 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations41 total
8,706 shares@ US$0.54850.7% of flowCommon StockSEC:0000950170-24-129257:0
10,609 shares@ US$0.86491.4% of flowCommon StockSEC:0000950170-24-122336:0
9,752 shares@ US$0.7791.1% of flowCommon StockSEC:0000950170-24-116645:0
1,493 shares@ US$0.81480.2% of flowCommon StockSEC:0000950170-24-112912:0
5,390 shares@ US$0.74130.6% of flowCommon StockSEC:0000950170-24-099846:0
3,091 shares@ US$0.75950.3% of flowCommon StockSEC:0000950170-24-099102:0
10,847 shares@ US$0.73481.2% of flowCommon StockSEC:0000950170-24-092807:0
9,731 shares@ US$0.75011.1% of flowCommon StockSEC:0000950170-24-085669:0
1,489 shares@ US$0.720.2% of flowCommon StockSEC:0000950170-24-081511:0
5,149 shares@ US$0.79230.6% of flowCommon StockSEC:0000950170-24-064052:0
3,075 shares@ US$0.74930.3% of flowCommon StockSEC:0000950170-24-062982:0
10,240 shares@ US$0.7961.2% of flowCommon StockSEC:0000950170-24-054512:0
9,601 shares@ US$0.75061.1% of flowCommon StockSEC:0000950170-24-046908:0
1,533 shares@ US$0.7720.2% of flowCommon StockSEC:0000950170-24-041810:0
3,097 shares@ US$0.69520.3% of flowCommon StockSEC:0000950170-24-018785:0
41,421 shares@ US$0.674.2% of flowCommon StockSEC:0000950170-24-011769:0
9,500 shares@ US$0.67040.9% of flowCommon StockSEC:0000950170-24-007406:0
1,664 shares@ US$0.6390.2% of flowCommon StockSEC:0000950170-24-002935:0
2,689 shares@ US$1.63110.7% of flowCommon StockSEC:0001209191-23-056313:0
4,382 shares@ US$1.69051.1% of flowCommon StockSEC:0001209191-23-056313:1
8,581 shares@ US$1.582.1% of flowCommon StockSEC:0001209191-23-053349:0
1,325 shares@ US$1.97630.4% of flowCommon StockSEC:0001209191-23-052229:0
11,361 shares@ US$2.49554.2% of flowCommon StockSEC:0001209191-23-046732:0
8,342 shares@ US$3.56154.3% of flowCommon StockSEC:0001209191-23-043121:0
5,275 shares@ US$3.04512.4% of flowCommon StockSEC:0001209191-23-041583:0
25 of 41 declarations
About Brainard Diana
Diana Brainard is the Chief Executive Officer and Director of Allovir, Inc. and Nektar Therapeutics. She oversees the operations and strategy of these biopharmaceutical companies, contributing to innovation and the development of new treatments.
